“Capital equipment financing” covers the ways a lab, department, or institution pays for a major instrument or system — a mass spectrometer, an ultra-low temperature freezer, a digital pathology scanner, a full CSSD sterilization line — without paying the full purchase price in cash at the time of acquisition. For a procurement officer or lab manager, the practical question is rarely “should we finance or not” in the abstract; it’s which financing structure fits a specific piece of equipment, a specific budget cycle, and a specific funding source, and what that structure actually costs and obligates the institution to once the paperwork is signed.
This guide walks through the real financing options, how leases are actually structured (the “true lease vs. finance lease” distinction that drives both accounting and tax treatment), how to compare leasing against a loan or outright purchase, and what the current federal tax rules allow. It is written for the buying decision itself — if your equipment lease is already signed and you need the accounting treatment under ASC 842, or the lease is funded by a federal award and subject to 2 CFR 200.465, see the dedicated guides linked throughout.
What capital equipment financing means
“Capital equipment” is equipment with a useful life beyond one year that gets capitalized on the balance sheet and depreciated over time, as opposed to a consumable or supply expensed immediately. “Capital equipment financing” is the umbrella term for the mechanisms used to acquire that equipment without a single upfront cash outlay: equipment leasing (several distinct structures, covered below), equipment loans, vendor/manufacturer financing programs, and lines of credit earmarked for capital purchases. Each mechanism has different effects on cash flow, balance-sheet presentation, tax treatment, and who owns the equipment at the end of the term — which is why the comparison has to happen on more than sticker price or monthly payment.
Equipment lease vs. loan: the core comparison
The two most common financing paths for lab capital equipment are a lease and an equipment loan (sometimes called an equipment finance agreement, or EFA). They solve the same cash-flow problem — spreading a large cost over time instead of paying it all at acquisition — but differ in a few ways that matter for a purchasing decision:
- Ownership. With a loan, the institution owns the equipment from day one; the lender holds a security interest (typically a UCC-1 filing against the equipment) until the loan is repaid. With a lease, the lessor (or a bank/finance company behind it) owns the equipment for the term of the lease; the lessee has use of it, not title, unless the lease is structured with a buyout.
- Down payment and collateral. Equipment loans typically require a down payment (often 10–20%) and the equipment itself serves as collateral. Leases can often be structured with little or no down payment, since the lessor retains ownership as its security.
- End-of-term outcome. A loan ends with the institution owning the equipment outright. A lease ends with one of several pre-negotiated options — return the equipment, renew the lease, or purchase it at a price set by the lease structure (fair market value, a fixed amount, or a nominal $1) — see lease types below.
- Obsolescence exposure. For equipment that turns over quickly (imaging systems, sequencers, some analytical instruments), a lease with a return or upgrade option shifts residual-value and obsolescence risk to the lessor. A loan or cash purchase leaves that risk with the institution.
- Accounting and tax treatment. This is where the specific lease structure matters most, and is covered in its own section below.
Types of equipment leases
Not all equipment leases are the same instrument. The structure you sign determines who can claim depreciation, how the lease is recorded on the balance sheet, and what happens at the end of the term. The commonly used structures for capital equipment are:
- Operating lease (fair market value, or FMV, lease). The lessor retains ownership and the tax benefits of ownership (depreciation); the lessee pays for use of the equipment over the term. At the end, the lessee typically has the option to return the equipment, renew, or purchase it at its then-current fair market value. Because the lessee doesn’t take on the risks and rewards of ownership, this is usually the “true lease” for tax purposes — payments are generally deductible as an operating expense rather than depreciated.
- Capital lease / finance lease ($1 buyout lease). Structured so ownership effectively transfers to the lessee at the end of the term for a nominal amount (commonly $1). Economically this functions like a loan: the lessee is treated as the owner for tax purposes, can typically claim depreciation (including Section 179 and bonus depreciation, see below), and the lease is recorded as a financed asset and liability rather than an off-balance-sheet operating cost.
- TRAC lease (terminal rental adjustment clause). Common for vehicles and some large mobile/movable equipment; the final payment is adjusted based on the equipment’s actual value at lease end. Less common for lab instruments than for fleet equipment, but worth knowing the term if a vendor proposes one.
- Vendor or manufacturer financing. Some equipment manufacturers and distributors offer financing or leasing directly, often through a captive finance arm or a partnership with a third-party lessor, bundled into the purchase process. The underlying structure is still one of the lease or loan types above — evaluate the actual terms (rate, buyout option, early-termination cost) the same way regardless of who is offering it.
True lease vs. finance lease
“True lease” and “finance lease” describe the same underlying distinction from two different angles — tax and accounting — and it’s easy to conflate them:
- For federal tax purposes (IRS guidance and case law, most directly summarized in factors from Rev. Rul. 55-540 and later guidance), a “true lease” is one where the lessor retains genuine ownership risk and benefit — a real residual stake in the equipment, not just a financing arrangement dressed up as a lease. If a lease is really a financed purchase in substance (nominal buyout, lease term close to the equipment’s useful life, no genuine residual risk to the lessor), the IRS can and does recharacterize it as a conditional sale, shifting depreciation and interest-deduction treatment to the lessee regardless of how the paperwork is labeled.
- For lease accounting purposes under ASC 842 (the standard that replaced the old “capital lease” terminology with “finance lease”), the classification test looks at five specific criteria — ownership transfer, a bargain purchase option, lease term relative to useful life, present value of payments relative to fair value, and whether the asset is so specialized it has no alternative use to the lessor. Meeting any one of them makes it a finance lease, recorded on the balance sheet as an asset and liability from day one; failing all five makes it an operating lease, which under ASC 842 still goes on the balance sheet (unlike the pre-2019 rules) but is expensed differently. For the full classification mechanics and a procurement checklist, see the dedicated guide: ASC 842 Lease Accounting: A Procurement Guide to Lab Equipment Leases.
The practical takeaway for a procurement decision: don’t rely on what a vendor’s paperwork calls the lease. Ask directly how the lease is expected to be classified for both tax and accounting purposes, and have finance/accounting confirm it before signing — the label on the term sheet is not authoritative.
Lease vs. buy equipment: a decision framework
There is no single right answer to lease-vs-buy; it depends on institutional factors that a procurement officer should work through explicitly rather than defaulting to whichever option a sales rep proposes:
- Funding source. Equipment bought with federal award funds is subject to specific cost-principle rules under 2 CFR 200.465 that treat rental/lease costs differently from a capital purchase, including special scrutiny for sale-leasebacks, related-party leases, and less-than-arm’s-length arrangements. If any portion of the funding is federal, work through that guide before finalizing a lease structure: Lease vs. Purchase Analysis for Federally Funded Equipment (2 CFR 200.465).
- Cash position and budget cycle. A cash purchase avoids financing costs entirely but requires the capital outlay up front, competing with every other capital priority in the same budget cycle. Leasing and loans convert a large one-time cost into a predictable recurring line item, which can matter more for departmental or grant-funded budgets than the total cost of financing.
- Expected useful life and technology turnover. Equipment expected to be replaced or upgraded well before it’s fully depreciated (some genomics, imaging, and analytical platforms) is a better fit for an operating lease with a return/upgrade path. Equipment expected to run its full useful life (centrifuges, autoclaves, general lab support equipment) is often cheaper over the long run to buy or finance toward ownership.
- Depreciation and tax position. An institution or a for-profit entity that can use depreciation deductions has an incentive to structure toward ownership (loan or finance lease) to capture Section 179 and bonus depreciation, discussed below. A nonprofit or tax-exempt institution with no tax liability to offset gets no benefit from that deduction, which shifts the calculus toward whichever structure has the better all-in financing cost, not the better tax treatment.
- Maintenance and service bundling. Some leases (particularly vendor/manufacturer-financed ones) bundle service contracts, calibration, and software updates into the payment. Price that bundle against buying the equipment and sourcing service separately — a lower monthly lease payment can still be the more expensive option once service is unbundled and compared like-for-like.
- Total cost of ownership, not just acquisition cost. Compare options on total cost over the equipment’s realistic useful life — financing charges, service, consumables, and disposal or trade-in value — not the acquisition price or monthly payment alone. See Medical Equipment Depreciation Life: Tax vs. Book Useful-Life for how useful-life assumptions feed into that comparison.
Equipment leasing tax benefits
Tax treatment is one of the more consequential differences between financing structures, and the current federal rules matter enough to check directly rather than assume from a prior year. Two provisions apply most directly to capital equipment:
- Section 179 expensing. Lets a taxpayer that owns qualifying equipment (purchased outright or via a lease/loan structured as a finance lease, where the lessee is treated as owner for tax purposes) deduct the full cost in the year placed in service, up to an annual limit, rather than depreciating it over years. For tax year 2026, the maximum Section 179 deduction is $2,560,000, with the deduction beginning to phase out once total qualifying purchases exceed a $4,090,000 threshold (IRS Publication 946).
- Bonus depreciation. Under the One Big Beautiful Bill Act (P.L. 119-21), qualifying property acquired and placed in service after January 19, 2025 is eligible for a 100% first-year bonus depreciation allowance, restoring the full immediate write-off after several years of a phased-down percentage under prior law. Taxpayers can elect a reduced allowance instead (40% generally, 60% for certain long-production-period property) for their first tax year ending after that date if that better fits their tax position.
Two things follow from this for a financing decision. First, these benefits are only useful to an entity with taxable income to offset — a nonprofit research institution, public university, or hospital system with no federal tax liability gets no direct value from Section 179 or bonus depreciation, so tax treatment should not be the deciding factor for those buyers (compare all-in financing cost instead). Second, for a taxable entity or a for-profit spinout, whether a specific lease actually qualifies for these deductions depends on how it’s classified as a true lease vs. finance lease for tax purposes (see above) — get that classification confirmed by tax counsel or the finance team before assuming a lease structure delivers a deduction it may not be entitled to.
For a founder-stage biotech or university spinout evaluating financing for the first time, including SBA loan programs and venture debt alongside leasing, see Startup Equipment Financing: Leases, Loans, and SBA Options for Lab Instruments.
Evaluating a capital equipment financing offer
Whether the financing is coming from a bank, an independent equipment finance company, or a vendor’s in-house program, evaluate every offer against the same checklist before signing:
- All-in cost, not just the payment. Get the effective interest rate or lease factor, not just the monthly payment — a lower payment over a longer term can cost more overall.
- End-of-term terms in writing. Confirm the buyout price (fair market value, fixed amount, or $1) and any renewal terms before signing, not at lease-end when negotiating leverage is weaker.
- Early termination and equipment substitution. Know the cost of terminating early or swapping equipment mid-term if research priorities change — a real risk for grant-funded or early-stage-program equipment.
- Insurance and risk allocation. Most equipment leases require the lessee to insure the equipment and bear risk of loss even though the lessor holds title; confirm what coverage is required and who is responsible for maintenance.
- UCC filings, for a loan. An equipment loan lender will typically file a UCC-1 financing statement against the equipment; confirm the filing is limited to the specific equipment financed, not a blanket lien on other institutional assets.
- Funding-source restrictions. If federal award funds are involved at any point, confirm the financing structure is compliant with 2 CFR 200.465 before signing — after-the-fact restructuring of a signed lease is far harder than getting it right up front.
- Documentation for institutional records. Keep the lease/loan agreement, the classification determination (true lease vs. finance lease, or loan), and the depreciation/expensing treatment together in the procurement file — auditors and grant reviewers will ask for exactly this documentation.
Frequently asked questions
What is capital equipment financing?
It’s any arrangement — a lease, an equipment loan, or a vendor financing program — that lets an institution acquire equipment with a useful life beyond one year without paying the full cost in cash at the time of purchase, spreading the cost over the equipment’s useful life or a negotiated term instead.
Is it better to lease or buy lab equipment?
It depends on funding source, expected useful life relative to technology turnover, cash position, and whether the buyer has taxable income to benefit from depreciation deductions. There’s no universal answer — work through the decision framework above rather than defaulting to whichever option a vendor proposes.
What’s the difference between an equipment lease and an equipment loan?
With a loan, the institution owns the equipment immediately and the lender holds a security interest until it’s repaid. With a lease, the lessor owns the equipment for the lease term, and the lessee has one of several possible end-of-term outcomes (return, renew, or purchase) depending on how the lease is structured.
What is a true lease?
A “true lease” is the tax-law term for a lease where the lessor retains genuine ownership risk and residual value in the equipment, as opposed to a financing arrangement structured to look like a lease. The IRS can recharacterize a lease lacking real lessor risk as a conditional sale, regardless of what the contract calls it.
Do equipment leases qualify for Section 179?
Only if the lease is structured and classified as a finance lease where the lessee is treated as the tax owner of the equipment — a true operating lease generally does not, since the lessor retains ownership for tax purposes. Confirm classification with tax counsel or your finance office before assuming a deduction applies.
Does a nonprofit or university benefit from equipment leasing tax benefits?
Generally no, directly — Section 179 and bonus depreciation only have value against taxable income, which most nonprofit research institutions, public universities, and hospital systems don’t have in the relevant sense. For these buyers, the financing decision should turn on all-in cost and cash flow, not tax treatment.
This guide covers capital equipment financing generally. For lease accounting mechanics under ASC 842, see ASC 842 Lease Accounting. For federally funded equipment specifically, see Lease vs. Purchase Analysis for Federally Funded Equipment (2 CFR 200.465). For early-stage biotech and spinout financing, see Startup Equipment Financing.
